ArticleRadiology case reports2022
Myocarditis on
Article in Radiology case reports, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
4 citing papers in PubMed.
- Emerging PET-radiotracers in cardiovascular, neuro-inflammation, lung and rheumatological diseases: a narrative review.EJNMMI reports · 2025Review
- Metabolic and Immune Crosstalk in Cardiovascular Disease.Circulation research · 2025Review
- Can FDG PET Serve as a Clinically Relevant Tool for Detecting Active Non-sarcoidotic Myocarditis?Nuclear medicine and molecular imaging · 2024Review
- Roles of MDA-LDL/OX-LDL/LOX-1 and TNF-α/TLR4/NF-κB Signaling Pathways in Myocardial Damage by Implantations of Cardiac Pacemakers in Elderly Patients.Current vascular pharmacology · 2024Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Myocarditis is the inflammation of the heart muscle with various clinical presentations and etiology. In this case, we demonstrate the utility of Fluorodeoxyglucose PET scan in identifying its etiology. A 28-year-old female with a history of undifferentiated connective tissue disease and sacroiliitis referred to the cardiology clinic for palpitations. Her symptoms started 3 years ago, were episodic, associated with fatigue, and impaired quality of her life. A resting electrocardiogram revealed sinus tachycardia. Medical workup for sinus tachycardia was unremarkable. Given suspicion for idiopathic myocarditis, a FDG PET using F18 was ordered and revealed diffuse myocardial uptake suggestive of myocarditis. Normal LV systolic function was noted on the echocardiogram. Her tachycardia was successfully treated with ivabradine and diltiazem. She was started on mycophenolate mofetil for myocarditis with improvement in symptoms of tachycardia and fatigue. A repeat FDG PET in follow-up revealed less diffuse uptake with the initiation of therapy. FDG-PET may add value in patients with inappropriate sinus tachycardia found especially if suspicion of underlying connective tissue disease exists. As illustrated in this case, a timely diagnosis could change management decisions as well as significantly impact the quality of life.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.